Prevalence of Intracranial Aneurysm in Hong Kong Chinese

Intracranial Aneurysm Clinical Trial

Official title:

Prevalence of Intracranial Aneurysm in Hong Kong Chinese

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01078506
• Other study ID #: GW006
• Status: Completed
• Phase: N/A
• First received: February 26, 2010
• Last updated: April 22, 2013
• Start date: January 2010
• Est. completion date: January 2013

Study information

• Verified date: April 2013
• Source: Chinese University of Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Health authority: Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

Intracranial aneurysm (localized dilatation in weakened blood vessel wall) rupture is a catastrophic disease, with half of the victims died and many of the survivors disabled. There is currently no data in the literature for the Chinese population concerning the prevalence, characteristics (location and size) and risk of harboring an unruptured intracranial aneurysm. In this study, the investigators aim to study the population prevalence and characteristics (location and size) of intracranial aneurysm in Hong Kong Chinese, and its cost-effectiveness. The screening is carried out using magnetic resonance angiography (MRA), with a 3-T magnetic resonance system, which is a well-established non-invasive method for intracranial aneurysm detection.

Description:

As charted below.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 21 Years to 65 Years

Eligibility

Inclusion Criteria:

• Healthy adults aged between 21 and 65 years

Exclusion Criteria:

• Contraindications to MRI

• History of known intracranial pathologies

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

• Aneurysm
• Intracranial Aneurysm

Locations

Country	Name	City	State
China	Department of Surgery, The Chinese University of Hong Kong	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Intracranial aneurysm		Three years	No
Secondary	Other intracranial pathologies		Three years	No